3,4-dihydroxyphenylacetic acid has been researched along with methylphenidate in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (57.89) | 18.7374 |
| 1990's | 5 (26.32) | 18.2507 |
| 2000's | 1 (5.26) | 29.6817 |
| 2010's | 2 (10.53) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Braestrup, C | 1 |
| Fuller, RW; Snoddy, HD | 2 |
| Meyer, JS; Woods, SK | 1 |
| Aburthnott, GW; Butcher, SP; Liptrot, J | 1 |
| Borcherding, BG; Elia, J; Keysor, CS; Mefford, IN; Potter, WZ; Rapoport, JL | 1 |
| Hurd, YL; Ungerstedt, U | 1 |
| Brown, GL; Chuang, LW; Karoum, F; Linnoila, M; Rapoport, JL; Wyatt, RJ; Zametkin, AJ | 1 |
| Buda, M; Gonon, FG; Suaud-Chagny, MF | 1 |
| Bero, L; Moore, KE; Nielsen, JA; Shannon, NJ | 1 |
| Hamburger, SD; Zametkin, AJ | 1 |
| Collin, AK; Sharp, T; Ungerstedt, U; Zetterström, T | 1 |
| de Sereville, JE; Duteil, J; Multon, MF; Pessonnier, J; Rambert, FA | 1 |
| Chapin, DS; Moore, KE; Nielsen, JA | 1 |
| Aoyama, T; Iga, T; Kotaki, H; Sawada, Y | 1 |
| McCann, U; Ricaurte, G; Yuan, J | 1 |
| Hirose, N; Kamei, J; Miyata, S; Oka, T; Saitoh, A; Yamada, M | 1 |
| Chiu, GS; Freund, GG; Gainey, SJ; Kaczmarczyk, MM; Kelley, KW; Kwakwa, KA; Lawson, MA; Machaj, AS; Martin, SA; Meling, DD; Miller, MJ; Newman, AF; Wang, Y; Woods, JA; York, JM | 1 |
| Danysz, W; Flik, G; Hauber, W; Russ, H; Sommer, S; Valastro, B | 1 |
1 trial(s) available for 3,4-dihydroxyphenylacetic acid and methylphenidate
| Article | Year |
|---|---|
Stimulant drug treatment of hyperactivity: biochemical correlates.
Topics: 3,4-Dihydroxyphenylacetic Acid; Attention Deficit Disorder with Hyperactivity; Child; Dextroamphetamine; Double-Blind Method; Epinephrine; Homovanillic Acid; Humans; Kidney; Male; Metanephrine; Methoxyhydroxyphenylglycol; Methylphenidate; Norepinephrine; Normetanephrine; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Vanilmandelic Acid | 1990 |
18 other study(ies) available for 3,4-dihydroxyphenylacetic acid and methylphenidate
| Article | Year |
|---|---|
Biochemical differentiation of amphetamine vs methylphenidate and nomifensine in rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amphetamines; Animals; Antidepressive Agents; Brain; Clorgyline; Dopamine; Homovanillic Acid; Humans; Isoquinolines; Male; Methylphenidate; Methyltyrosines; Monoamine Oxidase Inhibitors; Rats; Reserpine; Stereotyped Behavior | 1977 |
Inability of methylphenidate or mazindol to prevent the lowering of 3,4-dihydroxyphenylacetic acid in rat brain by amphetamine.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amphetamines; Animals; Brain Chemistry; Drug Interactions; Humans; Indoles; Male; Mazindol; Methylphenidate; p-Chloroamphetamine; Phenylacetates; Rats; Reserpine; Stereotyped Behavior | 1979 |
Synergistic elevation of brain 3,4-dihydroxyphenylacetic acid concentration by methylphenidate and spiperone in control but not reserpine-pretreated rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Butyrophenones; Drug Synergism; Methylphenidate; Phenylacetates; Rats; Reserpine; Spiperone | 1979 |
Exogenous tyrosine potentiates the methylphenidate-induced increase in extracellular dopamine in the nucleus accumbens: a microdialysis study.
Topics: 3,4-Dihydroxyphenylacetic Acid; Analysis of Variance; Animals; Dialysis; Dopamine; Extracellular Space; Male; Methylphenidate; Nucleus Accumbens; Osmolar Concentration; Rats; Rats, Inbred Strains; Tyrosine | 1991 |
Characterisation of methylphenidate and nomifensine induced dopamine release in rat striatum using in vivo brain microdialysis.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Chromatography, High Pressure Liquid; Corpus Striatum; Dialysis; Dopamine; Egtazic Acid; Homovanillic Acid; Kinetics; Male; Methylphenidate; Nomifensine; Rats; Rats, Inbred Strains; Reference Values; Reserpine; Stereotaxic Techniques; Tetrodotoxin | 1991 |
In vivo neurochemical profile of dopamine uptake inhibitors and releasers in rat caudate-putamen.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain Chemistry; Caudate Nucleus; Dialysis; Dopamine; Dopamine Agents; Homovanillic Acid; Indans; Male; Methylphenidate; Neurotransmitter Uptake Inhibitors; Nomifensine; Piperazines; Putamen; Rats; Rats, Inbred Strains | 1989 |
Stimulants, urinary catecholamines, and indoleamines in hyperactivity. A comparison of methylphenidate and dextroamphetamine.
Topics: 3,4-Dihydroxyphenylacetic Acid; Attention Deficit Disorder with Hyperactivity; Catecholamines; Child; Dextroamphetamine; Dopamine; Female; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Methylphenidate; Norepinephrine; Normetanephrine; Phenethylamines; Serotonin; Vanilmandelic Acid | 1985 |
Pharmacology of electrically evoked dopamine release studied in the rat olfactory tubercle by in vivo electrochemistry.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amphetamine; Animals; Apomorphine; Dopamine; Electric Stimulation; Electrochemistry; Electrodes; Haloperidol; Male; Medial Forebrain Bundle; Methylphenidate; Nomifensine; Olfactory Bulb; Rats; Reserpine; Sulpiride | 1989 |
Effects of acute and chronic bupropion on locomotor activity and dopaminergic neurons.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antidepressive Agents; Bupropion; Corpus Striatum; Dextroamphetamine; Dopamine; Male; Methylphenidate; Motor Activity; Propiophenones; Rats; Rats, Inbred Strains; Time Factors | 1986 |
The effect of methylphenidate on urinary catecholamine excretion in hyperactivity: a partial replication.
Topics: 3,4-Dihydroxyphenylacetic Acid; Attention Deficit Disorder with Hyperactivity; Catecholamines; Child; Dopamine; Homovanillic Acid; Humans; Male; Methoxyhydroxyphenylglycol; Methylphenidate; Norepinephrine; Normetanephrine; Vanilmandelic Acid | 1988 |
In vivo measurement of extracellular dopamine and DOPAC in rat striatum after various dopamine-releasing drugs; implications for the origin of extracellular DOPAC.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amphetamine; Animals; Corpus Striatum; Dopamine; Drug Interactions; Extracellular Space; Male; Methylphenidate; Nomifensine; Phenylacetates; Potassium Chloride; Rats; Rats, Inbred Strains | 1988 |
[Stereotyped movements and substantia nigra-corpus striatum dopaminergic function in the rat: action of methylphenidate after inhibition of monoamine oxidase].
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dopamine; Male; Methylphenidate; Monoamine Oxidase Inhibitors; Pargyline; Rats; Rats, Inbred F344; Rats, Inbred Strains; Stereotyped Behavior; Substantia Nigra | 1987 |
Differential effects of d-amphetamine, beta-phenylethylamine, cocaine and methylphenidate on the rate of dopamine synthesis in terminals of nigrostriatal and mesolimbic neurons and on the efflux of dopamine metabolites into cerebroventricular perfusates o
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Central Nervous System Agents; Cerebral Ventricles; Cocaine; Corpus Striatum; Dextroamphetamine; Dopamine; Dose-Response Relationship, Drug; Male; Methylphenidate; Neurons; Nucleus Accumbens; Olfactory Bulb; Phenethylamines; Rats; Rats, Inbred Strains | 1983 |
Pharmacokinetics and pharmacodynamics of methylphenidate enantiomers in rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dopamine; Dopamine Agents; Homovanillic Acid; Male; Methylphenidate; Motor Activity; Rats; Rats, Wistar; Stereoisomerism | 1996 |
Methylphenidate and brain dopamine neurotoxicity.
Topics: 3,4-Dihydroxyphenylacetic Acid; Analysis of Variance; Animals; Central Nervous System Stimulants; Dopamine; Dopamine Agents; Male; Methylphenidate; Mice | 1997 |
Effects of methylphenidate on the hyperemotional behavior in olfactory bulbectomized mice by using the hole-board test.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Behavior, Animal; Central Nervous System Stimulants; Dopamine; Emotions; Homovanillic Acid; Male; Methoxyhydroxyphenylglycol; Methylphenidate; Mice; Mice, Inbred ICR; Norepinephrine; Olfactory Bulb; Prefrontal Cortex | 2007 |
Methylphenidate prevents high-fat diet (HFD)-induced learning/memory impairment in juvenile mice.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antidepressive Agents; Anxiety; Blood Glucose; Body Weight; Brain-Derived Neurotrophic Factor; Central Nervous System Stimulants; Cerebral Cortex; Cytokines; Desipramine; Dietary Fats; Dopamine; Exploratory Behavior; Gene Expression Regulation; Hippocampus; Homovanillic Acid; Indoleamine-Pyrrole 2,3,-Dioxygenase; Learning Disabilities; Male; Maze Learning; Memory Disorders; Methylphenidate; Mice; Mice, Knockout; Monoamine Oxidase; Morpholines; Motor Activity; Overnutrition; Physical Endurance; Reboxetine; Receptors, Interleukin-1 Type I; Recognition, Psychology | 2013 |
The dopamine reuptake inhibitor MRZ-9547 increases progressive ratio responding in rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Benzhydryl Compounds; Central Nervous System Stimulants; Choice Behavior; Corpus Striatum; Dextroamphetamine; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Male; Methylphenidate; Modafinil; Motivation; Neuropsychological Tests; Rats, Sprague-Dawley; Reinforcement Schedule | 2014 |